The half-life (T|) of angiotensin II was measured in rats with chronic indwelling catheters. In conscious animals T i was 14.8±2.5 s; during anaesthesia 7*j increased by 60%. Anaesthesia decreased the control arterial pressure, but did not alter the sensitivity to injected angiotensin II. The causes and consequences of this change in angiotensin catabolism are discussed.
It is well known that barbiturate anaesthesia can cause significant changes in the cardiovascular and renin-angiotensin systems. For example, cardiac output, arterial pressure and the blood flows to most organs decrease (Price, 1960) ; plasma renin activity increases (Petdnger et al., 1975; Pettinger, 1978) ; the renal response to infused angiotensin II may be reversed (Navar and Langford, 1974) ; and the pressor response to angiotensin i.v. may decrease, largely as a result of inhibition of the c.n.s.-mediated component of this response (Dickinson and Ferrario, 1974) . Haas and colleagues (1969) , however, found that the pressor response to the intra-arterial administration of angiotensin II was enhanced by anaesthesia and they attributed this to an alteration in the retention of angiotensin by peripheral tissues. Therefore, we decided to investigate further the influence of anaesthesia on the rate of removal of angiotensin II using methods that have been developed recently (Al-Merani et al., 1978) . Our observation that barbiturate anaesthesia prolongs the half-life (7*^) of angiotensin II in the circulatory system by 60% may have relevance to many studies of the renin-angiotensin system.
METHODS

The conscious rat preparation
Female Wistar rats (250-300 g) were anaesthetized for a brief period with halothane and a nitrous oxideoxygen mixture. The right carotid artery and jugular vein were cannulated with PP25 polyethylene tubing (Portex). These cannulae were threaded under the skin, exteriorized at the back of the neck and secured by a stitch at this site. The cannulae were rilled with heparinized saline (50 i.u. ml" 1 ) and heat-sealed. The incision was sutured and the animals allowed to recover consciousness.
Measurement of T^ of angiotensin II
Two days after implantation of the catheters, each animal was placed in a restraining cage and the cannulae were flushed with heparinized saline. The venous cannula was connected to a pump for the infusion of angiotensin II (Qba, Hypertensin) and the arterial cannula connected to an Elcomatic EM750 (Elcomatic, Glasgow) arterial pressure transducer. Arterial pressure was recorded on a Vitatron potentiometric recorder (Fisons).
The half-lifr of angiotensin II was determined using the methods described in detail by Al-Merani and colleagues (1978) . Goldstein, Aranow and Kalman (1968) have shown theoretically and empirically that the plasma concentration of any hormone (or drug) is proportional to the dose administered; this is called the "plateau principle". Thus, any given infusion of angiotensin II (x ng min" 1 ) will result in a plasma concentration C ng/ml of plasma of the hormone, and a pressor response R! mm Hg. If twice the dose of angiotensin II is injected (2x ng min" 1 ), the peak concentration of angiotensin II will be 2Cngml~1, with a pressor response R'. Of course, this pressor response R' will not necessarily equal 2 x R'. As angiotensin II is catabolized after the infusion is stopped, the concentration in the plasma will decrease exponentially. When the pressor response has decreased from R* to R' the concentration in the plasma must have decreased from 2C to C, and the elapsed time must equal the half-life of the hormone. The application of this method to the measurement of T^ of angiotensin has been validated by Al-Merani and coworkers (1978) .
Thus changes in the plasma concentration of angiotensin II were deduced from studies of the rate of change of arterial pressure following the responses to infused doses of angiotensin II. For each animal a graph was constructed for various infusions of angiotensin II (10-1000 ng kg" 1 min" 1 ), showing the relationship between the plateau increase of arterial pressure and the concentration of angiotensin II in the plasma. This concentration of angiotensin II is proportional to the rate of infusion of angiotensin and can, therefore, be quantified in terms of the infusion rate. By reference to this graph, changes in the plasma concentration of angiotensin could be deduced (without taking blood samples) by examining the downsweep of the arterial pressure recording obtained when an infusion of angiotensin was stopped suddenly.
The T t of angiotensin was determined whilst each animal was conscious. In some animaisj anaesthesia was induced with sodium pentobarbitone 60 mg kg" 1 i.p. (Sigma) and 30 min later T^ of the hormone was redetermined. In a group of control animals anaesthesia was not induced, and two T i determinations were made 30 min apart. Thus, the whole procedure was repeated twice in each animal: two graphs were constructed showing change in arterial pressure v. dose of angiotensin II infused, so that any effect of anaesthesia upon this relationship cannot influence Tj determination.
The results are reported as the mean ± SEM and were evaluated by Student's t test as described by Colquhoun (1971) .
RESULTS
In seven rats, the half-life of angiotensin II was 14.8 ±2.5 s when the animals were conscious. This increased to 23.5 ± 3.5 s 30 min after the induction of barbiturate anaesthesia (P<0.05). Thus, the half-life increased by 59% (fig. 1A) . In four control animals T t of angiotensin was initially 14.2+ 1.9 s; this was not significantly different from the initial value obtained for the first group of rats (P>0.05). Thirty minutes later T i was redetermined with the animals still conscious, as 12.3± 1.4 s; this value was not significantly different from the initial measurement in this group (P>0.05) but was significantly less than the value obtained from the anaesthetized rats (P<0.05). In the seven experimental rats, anaesthesia reduced arterial pressure from 146 + 3 to 100 ±8 mm Hg (P< 0.001); in the four control animals the arterial pressure remained almost constant, being 143±3 initially and 139±6mmHg 30min later ( fig. 1B) . Fig. lc shows the average values of the plateau arterial pressure increases for each infusion of angiotensin II; the small differences between the two lines were not significant (P>0.05).
DISCUSSION
The methods used here to determine T i of angiotensin II have previously been tested extensively, and found to give valid results (Al-Merani ct al., 1978) . The values obtained for T^ of angiotensin II (12-25 s) are much smaller than values reported by most other workers, most of whom have used radioimmunoassay methods to determine angiotensin II concentrations (Ryan, 1974; Ledingham and Leary, 1974) . Ryan (1974) has suggested that radioimmunoassay methods probably detected the breakdown products of angiotensin catabolism and, therefore, underestimate the rate of angiotensin breakdown, a view supported by the measurements of Caravaggi and colleagues (1976) . Our control values for T t of angiotensin agree closely with those of Hodge, Ng and Vane (1967) who used bioassay methods to measure the abilities of various organs of the dog to destroy angiotensin II, and deduced T i of 15 s.
There is a possible objection to the methods employed in the present study. The relationship between the dose of angiotensin and the plateau pressor response is denned experimentally, and is shown in figure lc. However, this graph might not show the relationship between dose and arterial pressure when the angiotensin concentration is decreasing, particularly if the arterial pressure response disappears only slowly at a time when the angiotensin is decreasing rapidly. Thus the methods employed here might measure T i of the arterial pressure response, not 7^ of the hormone causing the arterial pressure response. Al-Merani and colleagues (1978) have established that this objection is not true and does not invalidate these methods. Angiotensin II was infused into rats until a steady increase in arterial pressure was obtained; in some instances the infusion of angiotensin II was switched off and the initial rate of decrease of arterial pressure was measured; in other instances the infusion of angiotensin II was maintained, but a large dose of saralasin was injected (saralasin blocks the angiotensin II receptors and thus prevents the angiotensin II from inducing its response) and the rate of decrease of arterial pressure was measured. Saralasin caused the arterial pressure to decrease more than twice as rapidly as did switching off the angiotensin II infusion. Thus the pressor response can easily change fast enough to indicate accurately the alterations in the concentration of angiotensin II.
Anaesthesia increased T t of angiotensin by 60%. Information in the literature leads to the conclusion that this change is probably the result of a combination of two phenomena: a decrease in the delivery of angiotensin to the sites of catabolism, and a decrease in the activity of the enzymes responsible for angiotensin catabolism. Angiotensin catabolism occurs predominantly in the capillary beds of most tissues other than lung, and occurs only slowly in the blood (Hodge, Ng and Vane, 1967) . Barbiturate anaesthesia is known to decrease the blood flows through most tissues and hence cardiac output (Price, 1960) . The decrease in cardiac output which follows barbiturate anaesthesia in the rat is reported to be between 20 and 30% (Popovic and Kent, 1964; Dawson, Nadel and Horvath, 1968) . Thus, the delivery of angiotensin II to the sites of angiotensin catabolism must decrease also, and should contribute significantly to the increased T t of angiotensin II. The enzymes in the peripheral capillary beds, which are responsible for angiotensin catabolism, are membrane-bound (Ryan, 1974; Lafontaine, Nivez and Ardaillon, 1979) . There is no direct evidence showing how angiotensinases are affected by barbiturates, but it is known that barbiturates dissolve in cell membranes, alter their physical properties (Lee, 1976) and increase the activity of some membranebound enzymes (Conney, 1967) , although decreasing the activity of others (Hertz, 1977) . It has been shown, however, that anaesthesia can decrease the removal of angiotensin by peripheral capillary beds (Haas et al., 1969) and this must also contribute to the increased T i of angiotensin II. The studies of Haas and co-workers (1969) suggest that plasma contains a factor which inhibits the retention of angiotensin by peripheral capillary beds, but these studies did not determine whether anaesthesia altered the circulating concentration of this factor.
A decrease in the rate of angiotensin catabolism should increase plasma concentrations of angiotensin. The observations of Miller, Longneck and Peach (1978) are in agreement with this since they have obtained evidence for enhanced angiotensin activity in anaesthetized animals when the renin concentrations were unaltered. Most workers find that anaesthesia leads to increased plasma renin activity (Pettinger, 1978) . Thus, very great circulating concentrations of angiotensin should be expected in anaesthetized animals.
The pressor responsiveness to angiotensin II was not altered significantly by anaesthesia in our experiments. There may be a number of factors which could change the sensitivity to angiotensin during anaesthesia, but these do not all act in the same direction. Dickinson and Ferrario (1974) found that barbiturate anaesthesia decreases the pressor response to angiotensin (especially when the angiotensin is injected into the arterial supply to the brain) by inhibiting a central nervous system component of the pressor response. However, our results show that barbiturate anaesthesia slows the rate of angiotensin II catabolism, so that any given rate of angiotensin infusion will cause a greater arterial concentration of the hormone and will, therefore, tend to cause a greater stimulation of all of the components of the pressor response; a similar conclusion has been reached by Haas and colleagues (1969) .
Angiotensin II can have two actions on kidney function. Small doses cause a sustained sodium retention, while large doses have a biphasic action, initially causing sodium retention which fades after a short time to give way to enhanced sodium excretion. There is evidence to show that the sodium retention and sodium excretion are mediated by independent mechanisms (Brooks, Chapman and Munday, 1979) ; the sodium retention with small and large doses of angiotensin II is probably dependent on the renal vasoconstrictor action of angiotensin II, while the sodium excreting action seen with a large dose of angiotensin II is probably caused by inhibition of sodium reabsorption (Navar and Langford, 1974) . There is evidence that anaesthesia can alter the response to angiotensin: a dose of angiotensin II which causes only sodium retention in a conscious animal causes the biphasic response expected of a large dose in an anaesthetized animal (Navar and Langford, 1974) . The present studies may help to explain this. Anaesthesia decreases angiotensin breakdown and a greater concentration of angiotensin must circulate in the plasma causing a greater stimulation of the sodium-excreting mechanisms; anaesthesia may also decrease the pressor and vasoconstrictor actions of angiotensin II and may attenuate the sodium-retaining actions of the hormone.
Anaesthesia is known to induce many interrelated changes in the renin-angiotensin system. The present studies, showing that anaesthesia prolongs 7"j of angiotensin in the circulation, may help to clarify some of these changes.
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SDMMARIO
Se llevaron a cabo mediciones de la media-vida (Tj) de la angiotensina II en ratones con sondas permanentes. En lo« animales conscientes, Tj era de 14,8 ± 2^ s; durante la anestesia, Tj aument6 en un 60%. La anestesia tuvo por efecto de disminuir la presi6n arterial de control, pero no alter6 la sensibilidad a la angiotensina II inyectada. Se discuten de las causas y consecuencias de esta modificad6n del cataboUsmo de la angiotensina.
